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Summary.-Cells from patients with chronic lymphocytic leukaemia (CLL) do not
respond in the mixed lymphocyte culture (MLC) but are able to stimulate the
response of normal lymphocytes.
Mixed lymphocyte cultures were performed using cells from 24 patients with CLL
and cells from 16 normal donors. The stimulatory capacity of8 of these CLL cells was
reduced when a common DR antigen was shared with the normal responding cell.
We suggest that cells from certain selected CLL patients may be used in the mixed-
lymphocyte reaction for determining the D-locus specificity of normal donors. CLL
cells which expressed I DR antigen only, induced more clearly defined typing
responses than cells with 2 DR antigens.
There was no correlation between the ability of a CLL cell to induce a typing
response and the T-cell status of the patient. However, a correlation with clinical
course was suggested, because most cells which induced a typing response were
obtained from patients who had received intensive treatment for the disease.
IN MAMMALIAN SPECIES there is a
region in the major histocompatibility
complex (MHC) concerned with the regu-
lation of immune responses (McDevitt &
Chinitz, 1969), called in man, HLA. This
region also codes for the Ia antigens which
are expressed on B, but not on T lympho-
cytes (unless activated), and in man they
are controlled by the DR locus. Another
function of this genetic region, controlled
by the D locus, concerns recognition and
response in the mixed lymphocyte culture
(MLC) (Bach & Amos, 1967). When two
populations of normal lymphocytes are
mixed together in vitro they stimulate
and respond to each other and enter DNA
synthesis (Bain et al., 1964). In order to
study the recognition and response of
normal lymphocytes, one population is
allowed to remain capable of cell division
(the responder population) and the other
(the stimulator population) is treated by
X-irradiation or mitomycin C so that the
cells cannot divide though they remain
antigenically intact (Kasakura & Lowen-
stein, 1965).
In mixed lymphocyte cultures B cells
act as stimulator cells and response is the
prerogative of T cells (McDermott et al.,
1975). It has been found that lymphocytes
of patients with chronic lymphocytic
leukaemia (CLL) provide an excellent
source of cells for B-cell serology. The
reactions with anti-DR sera are superior
to those given by enriched suspensions of
normal B cells (Lawler et al., 1978). We
therefore decided to investigate the be-
haviour of lymphocytes of CLL patients
as stimulators in the mixed lymphocyte
culture.
CLL cells cannot be uised as responders
in the mixed lymphocyte culture, so their
D-locus specificities cannot be deter-
mined, but the correlation with the DR
specificities means that the corresponding
D type can be deduced in most cases.
Our intention was to see whether the
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in mixed lymphocyte cultures could be
correlated with DR specificities and, if so,
whether they could be used in typing for
D-locus specificities. MLC-defined D-locus
specificities correlate with serologically
determined DR specificities for the anti-
gens we studied (Pickbourne et al., 1977).
In pilot studies, briefly reported at a
meeting of the Transplantation Society
in November 1978, we found that the
stimulating CLL cells showed some speci-
ficity. We therefore investigated a number
of patients of known clinical status and
DR type, to see whether there was any
common factor which determined whether
the CLL cell could be used for D-locus
typing.
MATERIALS AND METHODS
Patients and controls
Twenty-four patients with chronic lympho-
cytic leukaemia and 16 normal controls were
selected for the experiments on the basis of
their DR specificities. These cells had been
typed with sera used in the 6th, 7th and 8th
Histocompatibility Workshops (1975, 1977,
1980). DW specificities of the normal donors
wvere determined by using homozygous typing
cells obtained from recognised typing labora-
tories through Dr J. L. Sachs of the London
Hospital.
All CLL patients w-ere classified at diag-
nosis and at the time of the MLC, by Rai's
staging system (Rai et al., 1975) as follow-s:
Stage 0-Absolute lymphocytosis (> 15,000
lymphocytes x 106/I).
Stage I-Absolute lvmphocytosis +en-
larged lymph nodes.
Stage II-Absolute lymphocytosis +en-
larged liver and/or spleen.
Stage III Absolute lymphocytosis +an-
aemia (Hb <11 g/dl).
Stage IV - Absolute lymphocytosis +
thrombocvtopenia (platelet count < 100.000
x 106/1).
Techniques
Separation of lymphocytes for HLA-A, B, C
and DR typing.-Lymphocytes used for
HLA-A, B and C typing were separated from
heparinized blood on a Ficoll-Triosil gradient.
Suspensions of enriched B lymphocytes for
DR typing were separated from heparinized
blood by rosetting T lymphocytes with
papain-treated sheep erythrocytes following
the method of Welsh & Batchelor (1975,
personal communication). The suspensions
consisted of 70-90%o cells assessed by im-
munofluorescence after staining with fluores-
cein-labelled anti-humanglobulin (Welleome).
Cytotoxicity assayfor HLA-A, B, C and DR
antigens-.Lymplhocytes from CLL patients
and from normal controls were typed for
ABC antigens as follows: 1 yu of cell suspen-
sion (2 x 106 cells/ml in 500o AB serum: 500o
complement-fixation test buffer) was added
to 1 ,ul antisera in Terasaki plates. The cells
were incubated at room temperatuire for 30
min, 5 IA rabbit complement was then added
and after further incubation at room tem-
perature for 1 h, the percentage of dead cells
was estimated by trypan-blue exclusion.
The cytotoxic test used to type CLL cells
and B cells from normal controls for DR anti-
gens was similar to the method used for ABC
antigens, except that both incubation times
were doubled.
Mixed lymphocyte cultures (MLC).-Lym-
phocytes were obtained from fresh heparin-
ized blood samples and separated on a Ficoll-
Triosil gradient. Cells from patients with
CLL were frozen in 5000 autologous plasma
and 10% dimethyl sulphoxide, and thawed
when required. Normal cells were obtained
from donors on the day of culture and were
not frozen.
Cultures w%vere performed in triplicate in
microtest plates using equal concentrations
(5 x 104) of CLL cells (stimulator cells) and
normal lymphocytes (responder cells).
Lymphocytes were suspended in a total
volume of 100 ,ul of 25mM Hepes-buffered
RPMI 1640 (Gibco-Europe Ltd) containing
20% decomplemented pooled AB serum.
Culture medium was supplemented with
15mM sodium bicarbonate, 2mM glutamine.
penicillin (100,000 iu/l), and streptomycin
(100 mg/l). 0 5 ,uCi [3H]dT (5 Ci/mmol)
(Radiochemical Centre, Amersham) were
added to each culture after 5 days. After a
further 16 h the cultures were harvested in a
Minimash (Dynatech) and incorporation of
[3H]dT was measured by liquid scintillation
counting in a Packard autospectrometer.
Evaluation of MLC results.-MLC data
expressed as et/min were converted into a
"score" by calculatioin of "double normalized
values" based on the method of Ryder et al.
(1975) and Mendell et al. (1977).
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A double normalized value of 50 or less
was the figure selected by us to indicate a
typing response.
Lymphocyte marker studies.-Fresh cells
from the CLL patients were examined for the
presence of the following receptor sites: Fcy;
C3; SIgG, A, M, D (K and A). These investi-
gations were carried out by Dr J. L. Smith,
Regional Immunology Centre, Southampton.
The percentage of Ty lymphocytes was
assessed in 23 CLL patients by the method
of Moretta et al. (1975). The protocol and
antiserum were kindly supplied to us by
Professor J. R. Humphrey, Royal Post-
graduate Medical School.
RESULTS
Mixed lymphocyte cultures
We decided that a CLL cell could be
regarded as a typing cell ifmixed lympho-
cyte reactivity, expressed as the double
normalized value, was 50 or below in most
tests. The CLL cells were classified as
typing cells if the mixed lymphocyte
reactivity was reduced when there was a
common DR antigen between the CLL
cell and the normal cell. The CLL cells
were regarded as non-typing cells if there
was no reduction in mixed lymphocyte
TABLE I.-MLC response between CLL cells (stimulator) and normal cells (responder)
expressed as median ct/min and double normalized values (DNV)
Normal control i-
(responder) GW
t- ADR 2
Background
DR ct/min (379)
CLL (stimulator)
AC MW TK
2,3 2,3 2,3
(311) (629)
JP MD EP JM
3 4 7 7
(201) (240) (330) (449) (648)
NB
JQ
EJ
GE
VS
JS
SL
RF
GD
AH
LM
EN
LN
JT
1
2
2
2,1
2,3
2,3
2,4
3
3
3
3,7
3,7
4
4,5
(1,500)
(628)
(2,009)
(2,041)
(2,183)
(1,783)
(1,812)
(610)
(3,032)
(3,832)
(1,531)
(894)
(2,878)
(1,819)
DK 7 (3,716)
KG 7,2 (600)
t Median ct/min.
* Double normalized value.
ND = MLC not performed.
24,514t
100*
708
21-4
4,581
21-6
5,361
58-5
1,699
22
1,551
61-2
2,148
16-9
13,226
113-3
19,048
136-7
14,401
99
14,633
56-6
2,210
28
23,475
106-1
3,763
26-5
11,285
101-1
3,069
33
51,011
102-3
31,396
41-1
15,748
39-1
6,853
39-5
5,120
41-8
4,445
53-4
15,000
52
37,454
97-5
21,805
82-6
26,250
54-8
30,543
62-5
14,975
100
45,487
108-5
40,370
86-5
33,372
100
26,206
86-1
17,286
114
173
13-9
4,983
42-2
751
14-6
1,272
35-4
1,206
47-6
2,721
31-6
4,432
38-4
6,591
85
12,504
85-9
13,678
95-2
1,410
32
19,263
156-1
10,252
72-3
9,821
100
3,052
32-8
14,257
104-6
ND
ND
ND
1,132
16-4
2,347
103-3
1,369
17-2
2,075
19-5
ND
8,032
61-3
ND
ND
ND
12,346
96-8
3,091
30-8
1,811
21-6
23,842
58-9
27,919
103-2
31,500
89-6
17,368
114-5
3,821
35-7
ND
16,040
76-3
ND
8,445
36-7
ND
8,528
19-9
3,484
26-7
60,596
53.9
ND
101,684
104-3
43,030
100
32,812
110-6
ND
17,612
30-2
ND
31,625
49-5
ND
49,216
41-6
26,314
72-6
42,392
100
28,370
100
40,112
108-9
10,081
63-5
8,495
75-9
10,568
117-3
24,093
109-5
23,098
55-4
20,054
83-2
52,539
101-2
29,808
66-8
10,042
73-5
41,606 41,942 35,700
113-6 41-3 93-2
ND ND 32,438
64-1
29,134 69,058 9,199
100 85-5 30-2
ND ND 12,043
36-5
DNV of 50 or less in bold type.
32,864
83-1
ND
ND
ND
14,638
73-6
7,402
112-4
21,878
95-9
31,654
104-0
ND
32,219
84-9
ND
ND
ND
28,271
70-2
12,954
44-5
10,866
45
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reactivity when the responder cell shared
a DR antigen.
The 24 CLL cells tested were thus
classified into two categories; 16 of these
did not induce typing responses, but as
shown in Table I, cells from 8 of the
patients did induce a consistent typing
response.
Table I shows the response in the MLC
between responder (normal cell) and the
stimulator cell (CLL), expressed as median
ct/min and double normalized values
(DNV). The DNV of 50 or less are in bold
type, indicating a significant typing re-
sponse. Five of the CLL cells expressed
one DR antigen only (GW, JP, MD, EP,
JM). Three ofthe CLL cells expressed two
DR antigens (AC, MW, TK).
T'yping response for DR2
The CLL cell GWNr typed for DR2, and
stimu-lated normal cells lacking I)R2.
Both the normal cells expressing the DR2
antigen only (JQ, EJ) anid 3/5 cells
heterozygous for DR2 (VS, SL, KG)
showed a typing response.
DR3. Similarly the CLL cell JP typed
for DR3, and stimulated normal cells
lacking DR:3. Both the normal cells
expressing the DR3 antigen only (GD)
and 3/4 cells heterozygous for DR3 (VS,
LM, EN) showed a typing response.
DR4. The CLL cell MD typed for
DR4, and stimtulated normal cells lacking
DR4. The normal cell expressing DR4
only (LN) and one heterozygous for DR4
(SL), showed a typing response.
DR7. The CLL cells EP and JM typed
for DR7 aInd stimulated normal cells
lacking DR7. The normal cells expressing
DR7 only (DK and KG) showed a typing
response.
Where the stimulator anid respoinder
cell did not, share a common DR antigen,
the CLL cell rarely induced a typing
response. The CLL cell GCW typing for
DR2 showed two extra reactions with
DR2- normal cells, and CLL cell MD
typing for DR4 showed twvo extra typing
responses wvith DR4- cells. I'he cells
JE, EP and JM did not induce any extra
typing responses.
The 3 CLL cells which expressed both
DR2 and DR3 antigens gave a specific
typing response for DR2 only, and gave
poor typing responses for DR3. The
normal cells expressing DR2 only (JQ,
EJ), and 2/5 cells heterozygous for DR2
(GE, VS), showed a typing response to
the CLL cell AC (DR2, 3). The normal
cells expressing DR2 only (JQ, EJ) and
all 5 cells heterozygous for DR2 (GE, VS,
JS, SL, KG) showed a typing response to
the CLL cell MW (DR2, 3). Three of the
4 normal cells heterozygous for DR2
(VS, SL, KG) showed a typing response
to the CLL cell TK (DR2, 3). The CLL
cells AC and MW\ (lid not induce extra
typing responses and the CLL cell TK
induced one extra typing response to a
DR2- responder cell.
Table II shows the HLA types anid
sunmmarizes the clinical and haemato-
logical data of the 8 CLL patients whose
cells could be used as D-locus typing cells.
The results summarize the success of the
CLL cell as an inducer oftyping responses,
in relation to the DR type ofthe stimulator
and responder cell. Out of a total of 8
typing cells, 2 (MD, JP) expressed I
HLA-A and 1 HLA-B locus antigen and 5
(MD, JP, GW, EP and JM) expressed
I HLA-DR antigen only. CLL cells with
one antigen at the DR locus induced more
clearly defined typing responses than those
with 2 DR antigens. It appears that the
expression of 1 A and I B locus antigen is
not a prerequisite for a typing response.
Comparing the 8 CLL patients whose
cells behaved as typing cells with the
group of 16 patients whose cells did not,
there was no difference in the mean white
cell count, percentage of T lymphocytes or
percentage of Ty lymphocytes. Staging of
the patients at diagnosis and at the time
ofthe MLC revealed little difference in the
Rai classification in the two groups.
-DISCUSSION
The behaviour of CLL cells as stimula-
tors acnd responders in MLC has been
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studied previously. Cells from patients
with CLL have been used as stimulators
in mixed cell cultures with foetal liver
and thymus (Pegrum, 1971) and with
allogeneic normal lymphocytes (Ruhl et
al., 1975). The response of B lymphocytes
from CLL patients to B cell mitogens is
impaired (Godal et al., 1978). B cells from
CLL patients are thought to have either
an unimpaired stimulatory capacity in
the mixed lymphocyte reaction (Kasakura,
1975) or a decreased stimulatory capacity
(Wolos & Davey, 1979; Halper et al.,
1979). However, in our experiments,
calculation of the stimulator index for all
CLL cells used indicated that these were
effective stimulators provided they did
not share a common DR antigen with the
normal responder cell. It has been sug-
gested that optimal stimulation in the
MLC may be obtained by increasing the
concentration of CLL cells to 1X25-2X5 x
106/ml (Halper et al., 1979). In our experi-
ments we found that maximum stimula-
tion of normal responder cells occurred at
a concentration of 0 5 x 106/ml stimulator
cells, the mixed-lymphocyte reaction being
reduced at a lower concentration (0.25 x
106/ml) or a higher concentration (106/ml).
Other workers, though commenting on
the poor response induced by CLL cells
as stimulators, did not relate their findings
to the D or DR specificities ofthe respond-
ing cells (Kasakura, 1975).
Although not all the 16 CLL cells in our
study showed specificity in their stimulat-
ing capacity, 8 of them elicited a specific
typing response. This was sufficiently
reliable for us to suggest the possibility of
using these cells for determining the
D-locus specificity of normal donors.
There was no difference in median ct/min
or DNV between the group of cells which
induced a typing response and the group
of non-typing cells. This indicates that
the typing effect was produced by a factor
other than an overall reduction in median
ct/min or a reduction in stimulatory
capacity of the CLL cell.
We carefully examined the clinical and
haematological data of CLL patients, to
see whether any factors determined which
CLL cells could be used as a typing cell.
It has been suggested by Catovsky
et al. (1970) that although the percentage
of T lymphocytes is similar in treated and
untreated CLL patients, the increased
absolute number of T cells may have a
clinical significance.
We considered whether the percentage
of T cells in individual patients could be
correlated with the ability to give a typing
response. The percentage of T cells in
individual patients varied between 17%
and 4000, and there was no evidence that
the ability to induce a typing response
could be correlated with either the per-
centage of T cells or the mean T-cell
count (Table II).
In CLL an increase in the proportion
ancd absolute number of Ty suppressor
lymphocytes has been observed (Fauria et
al., 1980). We considered whether an in-
creased number of T suppressor cells could
account for the ability of certain CLL cells
to give a typing response, but as there was
no difference in the Ty cells between the
two groups, this was thought unlikely.
Twosub-populations ofB cellshave been
defined in CLL (Rudders, 1976). It appears
unlikely that the ability of CLL cells to
induce a typing response is related to the
sub-population class, as all except one of
the cases (FF) in this study were classified
as typical cells with polyclonal immuno-
globulin and a lack of intracellular immu-
noglobulin.
It appears that certain carefully selected
cells from patients with CLL can be used to
typeforDlocusspecificities. Thescarcity of
homozygous cells is a major disadvantage
ofD-locus typing. Keuning (1978) observed
that only 22 offspring from 209 con-
sanguineous marriages were homozygous
at the HLA-D locus. Therefore, substitu-
tion of CLL cells for D-locus typing could
be very useful.
To summarize our results: among 8
CLL cells that showed a typing response,
2 expressed one antigen only at the
HLA-A, B and DR loci, and another 3
had only one DR specificity. In the
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remaining 3 cases, although the cells had
2 DR specificities, they only elicited
a typing response to one DR antigen
(Table I).
Typing cells are usually selected for
homozygosity. It is hardly surprising,
therefore, that DR-heterozygous CLL cells
do not always give consistent results. We
claim that certain heterozygous CLL cells
may be used as typing cells, and although
these responses arevariable, itissignificant
that extremely few extra typing responses
are induced when the stimulator and
responder cell do not have a common DR
antigen.
As the typing responses are often
variable, it is necessary to use more than
one typing cell for each DR specificity,
especially when either the normal cell or
the CLLcellhas morethanoneDRantigen.
From our data it appears that typing
cells can be found by selecting patients
who have required intensive treatment for
their disease (Table II).
It is probable that certain CLL cells
behaved as typing cells due to a number
of factors which include the nature of the
disease and the amount of treatment
received. Typing responses were more
likely to be induced by cells from CLL
patients expressing one antigen at the
DR locus.
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